OCS Liver PROTECT Continued Access Protocol (CAP) Continuation

See also
Status	Clinical Trial	Phase
Completed	`NCT02798861` - Controlled Attenuation Parameter (CAP) in Liver Allografts
Completed	`NCT03527238` - Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine	Phase 2
Completed	`NCT01696331` - Text Messaging for Adherence in Adolescent Liver Transplant Recipients	N/A
Recruiting	`NCT05051605` - Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation
Recruiting	`NCT05940857` - Sponsor-Initiated OCS Liver Perfusion (OLP-II) Registry
Completed	`NCT01598987` - Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.	Phase 3
Active, not recruiting	`NCT05074160` - OCS Liver Perfusion (OLP) Post-Approval Registry
Completed	`NCT05087550` - Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation
Recruiting	`NCT04836923` - LIFT Intervention in Liver Transplant Candidates	N/A
Not yet recruiting	`NCT03666689` - Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation
Not yet recruiting	`NCT06088758` - Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool	N/A
Terminated	`NCT01230502` - Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation	N/A
Completed	`NCT00171509` - Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients	Phase 4
Not yet recruiting	`NCT06254248` - Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma	Phase 2
Recruiting	`NCT06075745` - Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates	Phase 2
Completed	`NCT02057484` - A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant
Active, not recruiting	`NCT03577431` - Liver Transplantation With Tregs at MGH	Phase 1/Phase 2
Recruiting	`NCT06342557` - Transitional ePRO Diary Liver
Not yet recruiting	`NCT04265157` - Hepato-duodenal Ligament Occlusion and Classic Technique in Liver Transplant
Recruiting	`NCT02863250` - Australian and New Zealand Massive Transfusion Registry

NCT number	NCT05096754
Study type	Observational
Source	TransMedics
Contact
Status	Completed
Phase
Start date	February 3, 2020
Completion date	February 2, 2023

OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms